BLGO Financials: BioLargo Inc AI Analysis



Financials

BLGO Financial

BioLargo Inc

$0.14

-7.62%

$-0.01

At close: May 11, 16:00:00 GMT-4

$0.14

Post-market: May 11, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$0.1515

Open

$0.15

Day's Range

$0.1276 - $0.15

52 week range

$0.1384 - $0.2576

Volume

1.0M

Avg.Volume

270.9K

Dividend yield

EPS (TTM)

-0.04

Market Cap

$44.7M

What is BLGO?

BioLargo, Inc. engages in the provision of technology solutions for odor and moisture control, disinfection, and water treatment. The company is headquartered in Westminster, California and currently employs 40 full-time employees. The Company’s core products address polyfluoroalkyl substances (PFAS) contamination, achieve advanced water and wastewater treatment, control odor and VOCs. The firm operates in distinct business segments, including ONM Environmental, which manufactures and sells its odor and VOC control products and services, including its flagship product, CupriDyne Clean; BLEST, which provides professional engineering services; Clyra Medical, which develops and sells medical products based on its technology; BETI, which develops its battery technology; BEST, which sells equipment based on its technology; BioLargo Canada, located in Edmonton, Alberta, Canada, has its primary research and development activities; and corporate operations, which support the operating segments with legal, accounting, human resources, and other services.

Features

Markets

News

Income

Balance sheet

Cash flow

Annual

Quarterly

BLGO Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024
Revenue	7	0	1	2	3	3
Revenue Growth (YoY)	-59%	-100%	-75%	-60%	-25%	-25%
Cost of Revenue	4	0	0	1	1	1
Gross Profit	3	0	0	1	1	1
Selling, General & Admin	11	3	3	2	2	2
Research & Development	2	0	0	0	0	0
Operating Expenses	14	4	3	3	3	3
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-15	-4	-7	-1	-1	-1
Income Tax Expense	--	--	--	--	--	--
Net Income	-11	-2	-6	-1	-1	-1
Net Income Growth	450%	100%	--	--	--	--
Shares Outstanding (Diluted)	314.28	314.28	308.97	303.19	301.27	301.21
Shares Change (YoY)	4%	4%	3%	2%	2%	4%
EPS (Diluted)	-0.03	0	-0.02	0	0	0
EPS Growth	376%	176%	1,067%	160%	171%	36%
Free Cash Flow	-8	-1	-2	-2	-1	-1
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	42.85%	0%	0%	50%	33.33%	33.33%
Operating Margin	-142.85%	0%	-300%	-50%	-33.33%	-33.33%
Profit Margin	-157.14%	0%	-600%	-50%	-33.33%	-33.33%
Free Cash Flow Margin	-114.28%	0%	-200%	-100%	-33.33%	-33.33%
EBITDA	-10	-3	-3	-1	-1	-1
EBITDA Margin	-142.85%	0%	-300%	-50%	-33.33%	-33.33%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-10	-3	-3	-1	-1	-1
EBIT Margin	-142.85%	0%	-300%	-50%	-33.33%	-33.33%
Effective Tax Rate	--	--	--	--	--	--

Follow-Up Questions

What are BioLargo Inc's key financial statements?



According to the latest financial statement (Form-10K), BioLargo Inc has a total asset of $0, Net loss of $0

What are the key financial ratios for BLGO?



BioLargo Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is BioLargo Inc's revenue broken down by segment or geography?



BioLargo Inc largest revenue segment is Odor-No-More Environmental, at a revenue of 5,905,000 in the most earnings release.For geography, United States is the primary market for BioLargo Inc, at a revenue of 7,765,000.

Is BioLargo Inc profitable?



no, according to the latest financial statements, BioLargo Inc has a net loss of $0

Does BioLargo Inc have any liabilities?



no, BioLargo Inc has liability of 0

How many outstanding shares for BioLargo Inc?



BioLargo Inc has a total outstanding shares of 0

BioLargo Inc (BLGO) Financial

BLGO Stock Price Chart